Biochemical markers of bone turnover - uses and limitations (Q38176560)

30 August 2017

Biochemical markers of bone turnover - uses and limitations (English)

1 reference

30 August 2017

Thinn Thinn Hlaing

1

1 reference

PubMed ID

24399365

30 August 2017

Juliet E Compston

series ordinal

2

1 reference

PubMed ID

24399365

30 August 2017

language of work or name

1 reference

7 January 2014

1 reference

Annals of Clinical Biochemistry

30 August 2017

1 reference

30 August 2017

51

1 reference

30 August 2017

189-202

1 reference

30 August 2017

Pt 2

1 reference

Remodeling and skeletal fragility

30 August 2017

1 reference

https://api.crossref.org/works/10.1177%2F0004563213515190

Biochemical markers of bone metabolism: an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004563213515190

Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004563213515190

Serum cathepsin K levels of patients with longstanding rheumatoid arthritis: correlation with radiological destruction

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004563213515190

Circulating C-terminal propeptide of type I procollagen is cleared mainly via the mannose receptor in liver endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004563213515190

Evaluation of a fully automated serum assay for total N-terminal propeptide of type I collagen in postmenopausal osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004563213515190

Teriparatide is safe and effectively increases bone biomarkers in institutionalized individuals with osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004563213515190

Short-term response of bone turnover to low-dose oral contraceptives in exercising women with hypothalamic amenorrhea

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004563213515190

Bone turnover markers: understanding their value in clinical trials and clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004563213515190

The use of biochemical markers of bone turnover in osteoporosis. Committee of Scientific Advisors of the International Osteoporosis Foundation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004563213515190

Analysis of human bone alkaline phosphatase isoforms: comparison of isoelectric focusing and ion-exchange high-performance liquid chromatography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004563213515190

Serum and urinary markers of bone remodeling: assessment of bone turnover

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004563213515190

Osteocalcin: diagnostic methods and clinical applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004563213515190

Molecular markers of bone and cartilage metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004563213515190

Serum TRACP 5b is a useful marker for monitoring alendronate treatment: comparison with other markers of bone turnover

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004563213515190

Clinical performance of immunoreactive tartrate-resistant acid phosphatase isoform 5b as a marker of bone resorption.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004563213515190

The measurement of pyridinium crosslinks: a methodological overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004563213515190

Markers of bone turnover for the management of patients with bone metastases from prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004563213515190

Odanacatib, a new drug for the treatment of osteoporosis: review of the results in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004563213515190

Circulating osteoprotegerin and receptor activator for nuclear factor kappaB ligand: clinical utility in metabolic bone disease assessment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004563213515190

Urinary markers of bone turnover in healthy children and adolescents: age-related changes and effect of puberty.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004563213515190

Urinary excretion of type I collagen crosslinked N-telopeptides in healthy Japanese adults: age- and sex-related changes and reference limits.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004563213515190

Preanalytical variability of biochemical markers of bone turnover.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004563213515190

Changes in bone mass and bone turnover following tibial shaft fracture.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004563213515190

The effects of twelve weeks of bed rest on bone histology, biochemical markers of bone turnover, and calcium homeostasis in eleven normal subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004563213515190

Biological variability of biochemical markers of bone turnover in healthy women

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004563213515190

Does osteoporosis therapy invalidate FRAX for fracture prediction?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004563213515190

Biochemical markers of bone turnover, hip bone loss, and fracture in older men: the MrOS study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004563213515190

Markers of bone resorption predict hip fracture in elderly women: the EPIDOS Prospective Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004563213515190

Identification of osteopenic women at high risk of fracture: the OFELY study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004563213515190

Bone resorption and osteoporotic fractures in elderly men: the dubbo osteoporosis epidemiology study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004563213515190

Bone turnover matters: the raloxifene treatment paradox of dramatic decreases in vertebral fractures without commensurate increases in bone density

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004563213515190

Relationships between bone mineral density and incident vertebral fracture risk with raloxifene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004563213515190

Pretreatment levels of bone turnover and the antifracture efficacy of alendronate: the fracture intervention trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004563213515190

Relationship of early changes in bone resorption to the reduction in fracture risk with risedronate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004563213515190

Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004563213515190

Denosumab for prevention of fractures in postmenopausal women with osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004563213515190

Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004563213515190

Two-year results of once-weekly administration of alendronate 70 mg for the treatment of postmenopausal osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004563213515190

The impact of monitoring on adherence and persistence with antiresorptive treatment for postmenopausal osteoporosis: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004563213515190

Usefulness of biochemical markers of bone turnover in assessing response to the treatment of Paget's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004563213515190

Long-term biochemical response after bisphosphonate therapy in Paget's disease of bone. Proposed intervals for monitoring treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004563213515190

Guidelines on the management of Paget's disease of bone

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004563213515190

Clinical features of metastatic bone disease and risk of skeletal morbidity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004563213515190

Evolving role of bone biomarkers in castration-resistant prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004563213515190

Biochemical markers of bone turnover in the clinical development of drugs for osteoporosis and metastatic bone disease: potential uses and pitfalls

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004563213515190

Bone markers and current laboratory assays

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004563213515190

Markers of bone turnover in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004563213515190

Clinical use of markers of bone turnover in metastatic bone disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004563213515190

Normalization of bone markers is associated with improved survival in patients with bone metastases from solid tumors and elevated bone resorption receiving zoledronic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004563213515190

Markers of bone turnover for the prediction of fracture risk and monitoring of osteoporosis treatment: a need for international reference standards.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004563213515190

21 January 2018

Identifiers

DOI

10.1177/0004563213515190

1 reference

30 August 2017

1 reference

PubMed ID

24399365